Form 4: Annexon CEO Douglas Love Exercises Stock Options and Acquires Shares

Annexon's CEO, Douglas Love, exercised stock options and acquired 37,994 shares of common stock on January 6, 2025.

Summary

• Douglas Love, the President and CEO of Annexon, Inc., exercised stock options to acquire 37,994 shares of common stock on January 6, 2025.
• The exercise price for the options was $1.4096 per share.
• Following the transaction, Mr. Love directly owns 356,575 shares of Annexon common stock.
• The transaction was reported on a Form 4 filing with the SEC.
• The shares acquired include 5,514 shares from May 15, 2024 and 2,497 shares from November 15, 2024, through the Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, indicating a positive sentiment due to the CEO's increased stake in the company, but it is not a major event.

Positives

• The CEO's exercise of stock options demonstrates confidence in the company's future prospects.
• The acquisition of shares through the Employee Stock Purchase Plan indicates employee participation and alignment with company goals.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies.

Comparison to Industry Standards

• Stock option exercises are a standard form of compensation for executives in publicly traded companies, particularly in the biotech sector.
• The exercise price of $1.4096 is specific to the terms of the options granted to Mr. Love and would be compared to other executive compensation packages within the biotech industry.
• The number of shares acquired is not unusual for a CEO of a company of Annexon's size and stage.

Stakeholder Impact

• The transaction increases the CEO's alignment with shareholder interests.
• The employee stock purchase plan participation benefits employees.

Key Dates

Keywords

stock options, insider trading, Form 4, executive compensation, share acquisition, Annexon, Douglas Love